Tonix Pharmaceuticals Holding (TNXP) FCF Margin (2023 - 2025)
Historic FCF Margin for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to 904.07%.
- Tonix Pharmaceuticals Holding's FCF Margin fell 2375200.0% to 904.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 741.06%, marking a year-over-year decrease of 1282700.0%. This contributed to the annual value of 604.77% for FY2024, which is 8099900.0% up from last year.
- Latest data reveals that Tonix Pharmaceuticals Holding reported FCF Margin of 904.07% as of Q3 2025, which was down 2375200.0% from 768.77% recorded in Q2 2025.
- Tonix Pharmaceuticals Holding's FCF Margin's 5-year high stood at 449.23% during Q2 2024, with a 5-year trough of 904.07% in Q3 2025.
- In the last 3 years, Tonix Pharmaceuticals Holding's FCF Margin had a median value of 674.67% in 2024 and averaged 669.64%.
- Its FCF Margin has fluctuated over the past 5 years, first soared by 2621700bps in 2024, then crashed by -3195400bps in 2025.
- Tonix Pharmaceuticals Holding's FCF Margin (Quarter) stood at 602.75% in 2023, then increased by 6bps to 566.73% in 2024, then crashed by -60bps to 904.07% in 2025.
- Its FCF Margin stands at 904.07% for Q3 2025, versus 768.77% for Q2 2025 and 682.79% for Q1 2025.